Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoxetine: a suitable long-term treatment.

H M Calil1

  • 1Department of Psychobiology, Universidade Federal de São Paulo, SP, Brazil. hmcalil@psicobio.epm.br

The Journal of Clinical Psychiatry
|October 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial.

Evidence-based complementary and alternative medicine : eCAM·2009
Same author

Family interventions for bipolar disorder.

The Cochrane database of systematic reviews·2007
Same author

Acute effects of low doses of melatonin on the sleep of young healthy subjects.

Journal of pineal research·2001
Same author

Clinical utility of the premenstrual assessment form as an instrument auxiliary to the diagnosis of premenstrual dysphoric disorder.

Psychiatry research·2000
Same author

MK-801 blocks the development of behavioral sensitization to the ethanol.

Alcoholism, clinical and experimental research·2000
Same author

Affective disorders, hospital admissions, and seasonal variation of mania in a subtropical area, southern hemisphere.

Psychopathology·1998
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Fluoxetine demonstrates a favorable safety profile for long-term use, showing fewer adverse events and discontinuation symptoms than other antidepressants. It is also safe for overdose and during pregnancy, with no observed teratogenic effects.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Neuroscience

Background:

  • Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for depression.
  • Long-term safety data for SSRIs, particularly fluoxetine, are crucial for clinical decision-making.
  • Understanding safety in special populations and during treatment cessation is essential.

Purpose of the Study:

  • To review the safety profile of fluoxetine, focusing on long-term treatment.
  • To compare fluoxetine's safety with other antidepressants, including tricyclic antidepressants and other SSRIs.
  • To evaluate fluoxetine's safety in overdose and in pregnant women.

Main Methods:

  • Systematic review of existing literature on fluoxetine safety.
  • Analysis of adverse event rates and dropout rates.

Related Experiment Videos

  • Examination of pregnancy outcome data following SSRI exposure.
  • Assessment of discontinuation symptoms after fluoxetine interruption.

    • Main Results:

    • Fluoxetine exhibits lower adverse events and dropout rates compared to tricyclic antidepressants and other SSRIs.
    • No teratogenic effects were observed in prospective pregnancy outcome studies following SSRI/fluoxetine exposure.
    • Discontinuation symptoms are absent or mild with fluoxetine, likely due to its long half-life.
    • Fluoxetine demonstrates safety in overdose situations.

    Conclusions:

    • Fluoxetine possesses a favorable safety profile for long-term treatment.
    • Its safety in overdose and pregnancy supports its suitability for diverse patient groups.
    • The mild discontinuation profile enhances patient adherence and treatment continuity.